🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 05370A108
- IPO
- 6/12/2020 · $18/share
Business: Avidity Biosciences, Inc. is pioneering a new class of oligonucleotide-based therapies called AOCs designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Avidity utilizes its proprietary AOC platform to design, engineer and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases.
Company Contact
- CEO
- Sarah Boyce
- CFO
- Michael F. MacLean
- Headquarters
- 10975 N. Torrey Pines Road, Suite 150, La Jolla, CA 92037
- Phone
- 858-401-7900
- Investor Relations
- Mike MacLean · 858-401-7900 · mikemac@aviditybio.com